TMDX FY 2024 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$442M+82.7% YoY

Gross Profit

$262M59.4% margin

Operating Income

$37M8.5% margin

Net Income

$35M8.0% margin

EPS (Diluted)

$1.01

Cash Flow

Operating Cash Flow

$49M

Free Cash Flow

-$81M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$804M

Total Liabilities

$575M

Stockholders' Equity

$229M

Cash & Equivalents

$337M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$442M	$242M	+82.7%
Gross Profit	$262M	$154M	+70.1%
Operating Income	$37M	-$29M	+230.5%
Net Income	$35M	-$25M	+241.7%